Retraction: A phase II, single-arm study of apatinib and oral etoposide in heavily pre-treated metastatic breast cancer

Frontiers in Oncology 2026 Open access

Read full text
Authors: Frontiers Editorial Office
DOI: 10.3389/fonc.2026.1798367
Cited by: 0

Abstract

[This retracts the article DOI: 10.3389/fonc.2020.565384.].

Fields of Study & Subjects

Breast Cancer Treatment Studies Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1798367–1798367
Publication date
10 February 2026
Language
EN